Benefits of bottom-up tissue engineering for pediatric cardiovascular implants.
Methods for imitating the layered tissue structure of artery and heart walls.
How technology is compatible with promising autologous cell sources.
Challenges including implant vascularization and preservation of cellular phenotype.